Monitoring blood flow responses during topical ALA-PDT

Photodynamic therapy (PDT) using topical 5-aminolevulinic acid (ALA) is currently used as a clinical treatment for nonmelanoma skin cancers. In order to optimize PDT treatment, vascular disruption early in treatment must be identified and prevented. We present blood flow responses to topical ALA-PDT in a preclinical model and basal cell carcinoma patients assessed by diffuse correlation spectroscopy (DCS). Our results show that ALA-PDT induced early blood flow changes and these changes were irradiance dependent. It is clear that there exists considerable variation in the blood flow responses in patients from lesion to lesion. Monitoring blood flow parameter may be useful for assessing ALA-PDT response and planning.

[1]  J.V. Moore,et al.  Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1‐year local control , 2003, The British journal of dermatology.

[2]  V. Schacht,et al.  Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[3]  Arjun G. Yodh,et al.  Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy , 2005, Clinical Cancer Research.

[4]  Daniel Rohrbach,et al.  Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report. , 2010, Optics express.

[5]  Chao Zhou,et al.  Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies. , 2007, Optics express.

[6]  Thomas H. Foster,et al.  Monitoring blood flow and photobleaching during topical ALA PDT treatment , 2009, BiOS.

[7]  P. Schurtenberger,et al.  Mode-selective dynamic light scattering: theory versus experimental realization. , 1995, Applied optics.

[8]  A. Sidoroff,et al.  Photodynamic therapy for non-melanoma skin cancer. , 2005, Acta dermato-venereologica.

[9]  Jarod C Finlay,et al.  Real-time In Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light , 2006, Photochemistry and photobiology.

[10]  Thomas H Foster,et al.  Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.

[11]  Thomas E. Milner,et al.  Microvascular photodynamic effects determined in vivo using optical Doppler tomography , 1999 .

[12]  D. Phillips,et al.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.

[13]  Sari Fien,et al.  Photodynamic therapy for non-melanoma skin cancer. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[14]  N. J. Brown,et al.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. , 1995, British Journal of Cancer.

[15]  Timothy C Zhu,et al.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[16]  B. Henderson,et al.  PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.

[17]  A. Yodh,et al.  In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies. , 2001, Physics in medicine and biology.

[18]  D. Boas.  Diffuse photon probes of structural and dynamical properties of turbid media: Theory and biomedical applications , 1996 .

[19]  M. Ericson,et al.  Review of photodynamic therapy in actinic keratosis and basal cell carcinoma , 2008, Therapeutics and clinical risk management.

[20]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[21]  N. Bendsøe,et al.  Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging. , 2000, Acta dermato-venereologica.

[22]  T. King,et al.  Aspects of laser light scattering from skin tissue with application to laser Doppler blood flow measurement. , 1984, Physics in medicine and biology.

[23]  T. Foster,et al.  Singlet Oxygen‐Versus Nonsinglet Oxygen‐Mediated Mechanisms of Sensitizer Photobleaching and Their Effects on Photodynamic Dosimetry , 1998, Photochemistry and photobiology.

[24]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[25]  B. Tromberg,et al.  Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. , 2007, Journal of biomedical optics.

[26]  Shoko Nioka,et al.  Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study. , 2006, Journal of biomedical optics.

[27]  K Svanberg,et al.  Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.

[28]  K. Svanberg,et al.  Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imaging , 1997, The British journal of dermatology.

[29]  C. Whitehurst,et al.  Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.

[30]  W. Star,et al.  Photodynamic Effectiveness and Vasoconstriction in Hairless Mouse Skin after Topical 5‐Aminolevulinic Acid and Single‐ or Two‐fold Illumination , 1999, Photochemistry and photobiology.

[31]  V. Krishnaswamy,et al.  System development for high frequency ultrasound-guided fluorescence quantification of skin layers. , 2010, Journal of biomedical optics.

[32]  Thomas H. Foster,et al.  Portable instrument that integrates irradiation with fluorescence and reflectance spectroscopies during clinical photodynamic therapy of cutaneous disease , 2006 .

[33]  A. Foss,et al.  Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour , 2003, The Journal of pathology.

[34]  H. Mukhtar,et al.  Photodynamic therapy in dermatology. , 2000, Journal of the American Academy of Dermatology.

[35]  D. Kessel,et al.  Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. , 1999, Journal of photochemistry and photobiology. B, Biology.

[36]  CLAUDE C. FRAZIER,et al.  PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.